Global Drug Eluting Stents (DES) Market 2017 Share, Size, Forecast 2022

Published On: Nov 2017

Format: PDF

Publisher: QY Research

Pages: 112

Report ID: 130613

In this report, the global Drug Eluting Stents (DES) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Drug Eluting Stents (DES) in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Drug Eluting Stents (DES) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Drug Eluting Stents (DES) for each application, including
Coronary Heart Disease
Clinical

Table of Contents

Global Drug Eluting Stents (DES) Market Research Report 2017
1 Drug Eluting Stents (DES) Market Overview
1.1 Product Overview and Scope of Drug Eluting Stents (DES)
1.2 Drug Eluting Stents (DES) Segment by Type (Product Category)
1.2.1 Global Drug Eluting Stents (DES) Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Drug Eluting Stents (DES) Production Market Share by Type (Product Category) in 2016
1.2.3 Cobalt-chromium alloy Stents
1.2.4 Magnesium alloy Stents
1.2.5 Tyrosine polycarbonate Stents
1.2.6 Nitinol Stents
1.2.7 Platinum chromium alloy Stents
1.2.8 Stainless steel Stents
1.2.9 Other Materials
1.3 Global Drug Eluting Stents (DES) Segment by Application
1.3.1 Drug Eluting Stents (DES) Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Global Drug Eluting Stents (DES) Market by Region (2012-2022)
1.4.1 Global Drug Eluting Stents (DES) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Drug Eluting Stents (DES) (2012-2022)
1.5.1 Global Drug Eluting Stents (DES) Revenue Status and Outlook (2012-2022)
1.5.2 Global Drug Eluting Stents (DES) Capacity, Production Status and Outlook (2012-2022)

2 Global Drug Eluting Stents (DES) Market Competition by Manufacturers
2.1 Global Drug Eluting Stents (DES) Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Drug Eluting Stents (DES) Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Drug Eluting Stents (DES) Production and Share by Manufacturers (2012-2017)
2.2 Global Drug Eluting Stents (DES) Revenue and Share by Manufacturers (2012-2017)
2.3 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Drug Eluting Stents (DES) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Drug Eluting Stents (DES) Market Competitive Situation and Trends
2.5.1 Drug Eluting Stents (DES) Market Concentration Rate
2.5.2 Drug Eluting Stents (DES) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Drug Eluting Stents (DES) Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Drug Eluting Stents (DES) Capacity and Market Share by Region (2012-2017)
3.2 Global Drug Eluting Stents (DES) Production and Market Share by Region (2012-2017)
3.3 Global Drug Eluting Stents (DES) Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Drug Eluting Stents (DES) Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Drug Eluting Stents (DES) Consumption by Region (2012-2017)
4.2 North America Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)
4.3 Europe Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)
4.4 China Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)
4.5 Japan Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)
4.7 India Drug Eluting Stents (DES) Production, Consumption, Export, Import (2012-2017)

5 Global Drug Eluting Stents (DES) Production, Revenue (Value), Price Trend by Type
5.1 Global Drug Eluting Stents (DES) Production and Market Share by Type (2012-2017)
5.2 Global Drug Eluting Stents (DES) Revenue and Market Share by Type (2012-2017)
5.3 Global Drug Eluting Stents (DES) Price by Type (2012-2017)
5.4 Global Drug Eluting Stents (DES) Production Growth by Type (2012-2017)

6 Global Drug Eluting Stents (DES) Market Analysis by Application
6.1 Global Drug Eluting Stents (DES) Consumption and Market Share by Application (2012-2017)
6.2 Global Drug Eluting Stents (DES) Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Drug Eluting Stents (DES) Manufacturers Profiles/Analysis
7.1 Abbott Vascular
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Abbott Vascular Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Advantec Vascular
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Advantec Vascular Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 B.Braun Melsengen AG
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Biosensors
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Biosensors Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Biotronik
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Biotronik Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Blue Medical
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Blue Medical Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Boston Scientific
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Boston Scientific Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 DISA Vascular
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 DISA Vascular Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Essen
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Essen Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Medtronic Vascular
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Drug Eluting Stents (DES) Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Medtronic Vascular Drug Eluting Stents (DES) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 MicroPort Medical
7.12 MIV Therapeutics
7.13 Orbusneich
7.14 Promed Medical
7.15 Relisys Medical
7.16 Reva Medical
7.17 Sahajanand
7.18 Sino Medical
7.19 Sorin
7.20 Terumo Medical

8 Drug Eluting Stents (DES) Manufacturing Cost Analysis
8.1 Drug Eluting Stents (DES) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Drug Eluting Stents (DES)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Drug Eluting Stents (DES) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Drug Eluting Stents (DES) Market Forecast (2017-2022)
12.1 Global Drug Eluting Stents (DES) Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Drug Eluting Stents (DES) Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Drug Eluting Stents (DES) Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Drug Eluting Stents (DES) Price and Trend Forecast (2017-2022)
12.2 Global Drug Eluting Stents (DES) Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Drug Eluting Stents (DES) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Drug Eluting Stents (DES) Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Drug Eluting Stents (DES) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer